Advertisement
Singapore markets close in 1 hour 8 minutes
  • Straits Times Index

    3,283.19
    -9.94 (-0.30%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,267.43
    +66.16 (+0.38%)
     
  • FTSE 100

    8,077.48
    +37.10 (+0.46%)
     
  • Bitcoin USD

    63,983.01
    -2,790.38 (-4.18%)
     
  • CMC Crypto 200

    1,388.89
    +6.32 (+0.46%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,334.60
    -3.80 (-0.16%)
     
  • Crude Oil

    83.02
    +0.21 (+0.25%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,569.14
    -2.34 (-0.15%)
     
  • Jakarta Composite Index

    7,160.42
    -14.11 (-0.20%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Halfords Shares Slump on Inflation Impact Warning

By Scott Kanowsky

Investing.com -- Shares in Halfords Group PLC (LON:HFD) slumped by more than 21% on Thursday, after the British cycling retailer warned "significant" cost inflation is having a negative impact on its financial performance.

The company added that it cannot forecast earnings for 2023 with "any degree of certainty," adding that the near-term outlook remains difficult due to an uptick in prices and a drop in demand for "higher ticket items."

"While rising inflation and declining consumer confidence will naturally present short-term challenges for any customer-facing business like ours, we remain confident in Halfords’ long-term growth prospects due to our service-led strategy and the enduring strength of our brand, people, products and services,” said Halfords chief executive Graham Stapleton in a statement.

ADVERTISEMENT

In its preliminary full-year results, the group reported a 49.8% year-on-year rise in pre-tax profit, up to £96.6M. Revenue also increased by 6% to £1.37B.

Related Articles

Halfords Shares Slump on Inflation Impact Warning

Walgreens enters clinical trials business through new unit

Abbott halts EleCare output from plant at center of baby formula shortage